Cargando…

Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

BACKGROUND: Whether differences in circulating long chain acylcarnitines (LCAC) are seen in heart failure (HF) patients with and without diabetes mellitus (DM), and whether these biomarkers report on exercise capacity and clinical outcomes, remains unknown. The objective of the current study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Truby, Lauren K., Regan, Jessica A., Giamberardino, Stephanie N., Ilkayeva, Olga, Bain, James, Newgard, Christopher B., O’Connor, Christopher M., Felker, G. Michael, Kraus, William E., McGarrah, Robert W., Shah, Svati H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336082/ https://www.ncbi.nlm.nih.gov/pubmed/34344360 http://dx.doi.org/10.1186/s12933-021-01353-z

Ejemplares similares

Plasma acylcarnitines are associated with pulmonary hypertension
por: Luo, Nancy, et al.
Publicado: (2017)

Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street
por: White, Phillip J., et al.
Publicado: (2021)

Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes
por: Lerman, Joseph B., et al.
Publicado: (2022)

Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
por: Hunter, Wynn G., et al.
Publicado: (2016)

Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
por: McGarrah, Robert W., et al.
Publicado: (2022)

Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export
por: White, Phillip J., et al.
Publicado: (2016)

Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity
por: Grenier-Larouche, Thomas, et al.
Publicado: (2022)

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes
por: Regan, Jessica A., et al.
Publicado: (2023)

Branched‐Chain Amino Acids in Computed Tomography–Defined Adipose Depots and Coronary Artery Disease: A PROMISE Trial Biomarker Substudy
por: Zhao, Elizabeth, et al.
Publicado: (2023)

Novel plasma biomarkers improve discrimination of metabolic health independent of weight
por: Ellison, Stephen, et al.
Publicado: (2020)

NMR Characterization of Long-Chain Fatty Acylcarnitine Binding to the Mitochondrial Carnitine/Acylcarnitine Carrier
por: Zhang, Ningning, et al.
Publicado: (2022)

If You’re Ready, I Am Ready (But the Wait Is Harming Us Both) Individual Risks in Institutional Conversions
por: Sharp, Mindy McGarrah
Publicado: (2020)

Pedagogies of Possibilities: Liberating Moral Imagination by Practicing Pastoral Aesthetics
por: Sharp, Melinda A. McGarrah
Publicado: (2021)

Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart
por: Walejko, Jacquelyn M., et al.
Publicado: (2021)

Long-Chain Acylcarnitines Regulate the hERG Channel
por: Ferro, Fabio, et al.
Publicado: (2012)

Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women
por: Huffman, Kim M., et al.
Publicado: (2009)

Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues
por: Makrecka-Kuka, Marina, et al.
Publicado: (2017)

Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
por: Nowak, Christoph, et al.
Publicado: (2018)

Long-Chain Acylcarnitines and Cardiac Excitation-Contraction Coupling: Links to Arrhythmias
por: Aitken-Buck, Hamish M., et al.
Publicado: (2020)

The significance of acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency
por: Shi, Congcong, et al.
Publicado: (2023)

Acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency in newborns
por: Tan, Yifei, et al.
Publicado: (2023)

Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy
por: Okonko, Darlington O., et al.
Publicado: (2019)

Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men
por: Ribel‐Madsen, Amalie, et al.
Publicado: (2016)

Effect of Roux-en-Y Gastric Bypass and Laparoscopic Adjustable Gastric Banding on Branched-Chain Amino Acid Metabolism
por: Magkos, Faidon, et al.
Publicado: (2013)

Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge
por: Bain, James R., et al.
Publicado: (2009)

Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy
por: McCann, Gerry P., et al.
Publicado: (2015)

Early mobilization after total hip or knee arthroplasty: a substudy of the POWER.2 study
por: Ripoll..s-Melchor, Javier, et al.
Publicado: (2021)

OR14-5 Branched-chain Amino Acid and Tryptophan Metabolism and the Pathogenesis of Youth-Onset Type 2 Diabetes Mellitus (T2D)
por: Armstrong, Sarah, et al.
Publicado: (2022)

A Plasma Long‐Chain Acylcarnitine Predicts Cardiovascular Mortality in Incident Dialysis Patients
por: Kalim, Sahir, et al.
Publicado: (2013)

Decreases in Circulating Concentrations of Long-Chain Acylcarnitines and Free Fatty Acids During the Glucose Tolerance Test Represent Tissue-Specific Insulin Sensitivity
por: Makarova, Elina, et al.
Publicado: (2019)

2,6-Anhydro-1,3-di-O-benzyl-d-mannitol
por: de Siqueira, Edmilson Clarindo, et al.
Publicado: (2011)

Dimethyl hydrazine-1,2-dicarboxylate–triphenylphosphine oxide (1/1)
por: Doboszewski, Bogdan, et al.
Publicado: (2011)

Enhanced Acylcarnitine Annotation in High-Resolution Mass Spectrometry Data: Fragmentation Analysis for the Classification and Annotation of Acylcarnitines
por: van der Hooft, Justin J. J., et al.
Publicado: (2015)

Associations Between Dietary Protein Sources, Plasma BCAA and Short-Chain Acylcarnitine Levels in Adults
por: Rousseau, Michèle, et al.
Publicado: (2019)

Acylcarnitines: Reflecting or Inflicting Insulin Resistance?
por: Schooneman, Marieke G., et al.
Publicado: (2013)

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
por: Mu, Xiaodie, et al.
Publicado: (2022)

Acylcarnitines in Ophthalmology: Promising Emerging Biomarkers
por: Theodoridis, Konstantinos, et al.
Publicado: (2022)

Recommendations for Improving Identification and Quantification in Non-Targeted, GC-MS-Based Metabolomic Profiling of Human Plasma
por: Wang, Hanghang, et al.
Publicado: (2017)

Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome
por: Mednova, Irina A., et al.
Publicado: (2022)

Heart-Type Fatty Acid Binding Protein Binds Long-Chain Acylcarnitines and Protects against Lipotoxicity
por: Zelencova-Gopejenko, Diana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qnj2fgjd7sheibnbbbbl7e5ecb